Citation: | P EI Jia-ping, JI Xiao-wei, JIANG Long-feng, DENG Xiao-zhao, XU Xiao-dong, XIAO Wen, DING Wei-liang, ZHANG Jin-hai, WANG Chang-jun, ZHU Dan-yan, LI Bing-jun. Association of HLA-DPA1/B1 gene polymorphisms with the susceptibility and outcomes of hepatitis C virus infection[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2016, 20(2): 112-115,120. doi: 10.16462/j.cnki.zhjbkz.2016.02.002 |
Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors [J]. JAMA, 2000,284(4):450-456.
|
Li D, Long Y, Wang T, et al. Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China [J]. PLoS One, 2013,8(1):e54815.
|
朱丹燕,鲁卫东,邓小昭,等. 丙型肝炎病毒F蛋白上调人外周血单个核细胞IL-13的表达 [J]. 中华疾病控制杂志, 2015,19(2):115-118
,126.
|
薛兴欣,蔡立,王佳佳,等. 有偿献血人群血浆IL-18水平与HCV感染及其基因型的相关性研究 [J]. 中华疾病控制杂志, 2014,18(7):590-593.
|
Wahle RC, Perez RM, Pereira PF, et al. Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection [J]. Braz J Infect Dis, 2015,19(5):533-537.
|
Osburn WO, Fisher BE, Dowd KA, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection [J]. Gastroenterology, 2010,138(1):315-324.
|
Fernandez-Ponce C, Dominguez-Villar M, Aguado E, et al. CD4+ primary T cells expressing HCV-core protein upregulate foxp3 and IL-10, suppressing CD4 and CD8 T cells [J]. PLoS One, 2014,9(1):e85191.
|
Yue M, Deng X, Zhai X, et al. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients [J]. Immunol Lett, 2013,152(2):89-95.
|
Mohamadkhani A, Katoonizadeh A, Poustchi H, et al. Immune-regulatory events in the clearance of HBsAg in chronic hepatitis B:focuses on HLA-DP [J]. Middle East J Dig Dis, 2015,7(1):5-13.
|
McLaughlin KA, Gulati K, Richardson CC, et al. HLA-DR4-associated T and B cell responses to specific determinants on the IA-2 autoantigen in type 1 diabetes [J]. J Immunol, 2014,193(9):4448-4456.
|
Duquesnoy RJ, Marrari M, Tambur AR, et al. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry [J]. Hum Immunol, 2014,75(11):1097-1103.
|
Huang P, Zhang Y, Lu X, et al. Association of polymorphisms in HLA antigen presentation related genes with the outcomes of HCV infection [J]. PLoS One, 2015,10(4): e0123513.
|
Straetemans T, van Brakel M, van Steenbergen S, et al. TCR gene transfer: MAGE-C2/HLA -A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets [J]. Clin Dev Immunol, 2012,2012:586314.
|
中华医学会传染病与寄生虫病学分会、肝病学会议. 病毒性肝炎防治方案 [J]. 中华传染病学杂志, 2004,22(2):131-134.
|
Han KH, Yoon KT. New diagnostic method for liver fibrosis and cirrhosis [J]. Intervirology, 2008,51(Suppl 1):11-16.
|
刘志权,冯军花,孝奇,等. 瞬时弹性扫描仪对慢性乙型肝炎肝纤维化的诊断价值研究 [J]. 中国全科医学, 2012,15(35):4068-4070.
|
Xu X, Yue M, Jiang L, et al. Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population [J]. Int J Mol Sci, 2014,15(6):9826-9843.
|
陆冰云,李婷婷. 丙型肝炎病毒相关正向和负向T细胞免疫应答的研究进展 [J]. 广东医学, 2014,35(20):3265-3267.
|
Ferre AL, Hunt PW, McConnell DH, et al. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-Cell responses [J]. J Virol, 2010, 84(21):11020-11029.
|
Shaker O, Bassiony H, EI Raziky M, et al. Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4 [J]. Mediators Inflamm, 2013,2013:392746.
|